Experiments are done at Kyoto University Research Reactor Institute’s Oncology Center
Stella Pharma press release, Sept. 6, 2012
Stella Pharma announces first clinical trial on oncotherapy using boron neutron capture therapy (BNCT): partners are Sumitomo Heavy Industries and Kyoto University